Document is current
Any future updates will be listed below
-
Authors
Zhang, Xiaolin
Yang, Mengbo
Chen, Xinda
Zhang, Ming
Peng, Yiliang
Lu, Mujun https://orcid.org/0000-0002-5946-2061
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82171611)
National Natural Science Foundation of China (82371631)
National Natural Science Foundation of China (82401887)
Key Technologies Research and Development Program (SQ2024YFA1100180)
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 23 January 2025
First Online: 25 February 2025
Declarations
:
: The study of “Application of mesenchymal stem cells in cavernous nerve injury-induced erectile dysfunction” was approved by the Ethics Committee of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine on Oct.26, 2022, with approval number KY2022-180-B. The patients provided written informed consent for participation in the study and the use of samples.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
